Amyloidosis and alzheimer's disease diagnostic assay and reagent

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548178, A61K 4902, C07D27762

Patent

active

050395114

ABSTRACT:
The presence and location of amyloid deposits in an organ or body area of a patient is effected by intravenous administration of novel radioactive iodine-labeled amyloid binding compounds and preferably .sup.123 I-labeled compounds to the patient and sensing radiation emitted from the organ or body area. Novel non-radioactive iodine substituted amyloid binding compounds and amyloid binding compounds which are readily iodinated are further aspects of the invention

REFERENCES:
patent: 4435570 (1984-03-01), Nishimura et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amyloidosis and alzheimer's disease diagnostic assay and reagent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amyloidosis and alzheimer's disease diagnostic assay and reagent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amyloidosis and alzheimer's disease diagnostic assay and reagent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1526381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.